Goldman Sachs initiates coverage on Auxilium Pharmaceuticals (NASDAQ: AUXL) with a Buy. PT $23.00.

The firm said investors are ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE